MedPath

Prospective study of efficacy of prophylactic hemostasis for ulceration post endoscopic submucosal dissection of early gastric tumor.

Not Applicable
Conditions
Early gastric cancer and adenoma
Registration Number
JPRN-UMIN000004394
Lead Sponsor
School of Medicine, Osaka, Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
260
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patient with major organ failure(heart failure,renal failure,liver failure, Respiratory failure) 2, Patients who have anticoagulant or antiplatelet therapy and who cannot stop it. 3.Patient with Pacer planting 4. Patients who were judged inappropriate by their physicians.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retio of delayed bleeding(hematemesis or melena required endoscopic hemostasis, decreased the hemoglobin count by more than 2g/dl)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath